AYALA PHARMACEUTICALS INC (AYLA)
Institutional ownership reported to the SEC as of Q4 2022, across 11 quarters.
7
Reporting holders
$45.5K
Reported value
0.0%
Held as options
-7
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $23.9K | 56,900 | 0.00% | 8q | -30.5%-$10.5K |
| TWO SIGMA SECURITIES, LLC | $6.4K | 16,063 | 0.00% | 2q | -24.3%-$2.1K |
| MORGAN STANLEY | $5.6K | 13,931 | 0.00% | 2q | -12.8% |
| CITADEL ADVISORS LLC | $4.8K | 11,415 | 0.00% | new | NEW |
| Avantax Planning Partners, Inc. | $4.0K | 10,000 | 0.00% | new | NEW |
| Harel Insurance Investments & Financial Services Ltd. | $862 | 2,153,273 | 0.02% | 7q | HELD |
| UBS Group AG | $404 | 1,010 | 0.00% | new | NEW |
| Ameliora Wealth Management Ltd. | $316 | 750 | 0.00% | 2q | HELD |
| RENAISSANCE TECHNOLOGIES LLC | $21 | 53,600 | 0.00% | 3q | +11.7% |
| Psagot Value Holdings Ltd. / (Israel) | $14 | 36,232 | 0.00% | 2q | -40.6% |
| GEODE CAPITAL MANAGEMENT, LLC | $4 | 10,596 | 0.00% | 4q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2022 | 7 | $45.5K | 110,069 | 3 | 0 | 3 | 0.0% |
| Q3 2022 | 14 | $2.6M | 2,576,747 | 8 | 1 | 1 | 0.0% |
| Q2 2022 | 13 | $4.6M | 4,196,371 | 4 | 1 | 4 | 0.0% |
| Q1 2022 | 14 | $18.8M | 4,735,215 | 2 | 5 | 4 | 0.0% |
| Q4 2021 | 13 | $41.7M | 4,903,708 | 5 | 5 | 2 | 0.0% |
| Q3 2021 | 13 | $30.6M | 2,700,453 | 2 | 4 | 3 | 0.0% |
| Q2 2021 | 12 | $20.9M | 2,052,002 | 4 | 2 | 4 | 0.0% |
| Q1 2021 | 11 | $22.3M | 2,046,142 | 5 | 3 | 2 | 0.0% |
| Q4 2020 | 7 | $19.4M | 1,715,643 | 1 | 1 | 4 | 0.0% |
| Q3 2020 | 7 | $19.2M | 1,635,931 | 3 | 1 | 2 | 0.0% |
| Q2 2020 | 7 | $17.9M | 1,787,604 | 7 | 0 | 0 | 0.0% |